Daniel Wagner
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 2
- Pharmacogenetics and Drug Metabolism 2
-
- Drug Solubulity and Delivery Systems 2
- Co-authors
- Peter Langguth (4 shared papers)Hilde Spahn-Langguth (2 shared papers)W.P. Jones (2 shared papers)E. H. Flewellen (2 shared papers)Abeer Hanafy (1 shared paper)JOHN D. CONKLIN (4 shared papers)Michael B. Bolger (1 shared paper)Wolfgang Tremel (1 shared paper)
- Journals
- British Journal of Pharmacology (2 papers)International Journal of Pharmaceutics (2 papers)Journal of Pharmaceutical Sciences (1 paper)Strahlentherapie und Onkologie (1 paper)Advanced Drug Delivery Reviews (1 paper)
- Partner nations
- United StatesGermanyLuxembourg
In The Last Decade
Daniel Wagner
16 papers receiving 349 citations
Peers
Comparison fields: 5 of 69
- Pharmaceutical Science 101
- Pharmacology 56
- Oncology 96
- Anesthesiology and Pain Medicine 19
- Cardiology and Cardiovascular Medicine 62
Countries citing papers authored by Daniel Wagner
This map shows the geographic impact of Daniel Wagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Wagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Wagner more than expected).
Fields of papers citing papers by Daniel Wagner
This network shows the impact of papers produced by Daniel Wagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Wagner. The network helps show where Daniel Wagner may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Wagner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 138 | |
| 2 | 2001 | 104 | |
| 3 | 2006 | 56 | |
| 4 | 2006 | 19 | |
| 5 | 1969 | 14 | |
| 6 | 2003 | 13 | |
| 7 | 2024 | 11 | |
| 8 | 1971 | 10 | |
| 9 | 1973 | 8 | |
| 10 | 2013 | 5 | |
| 11 | 1995 | 5 | |
| 12 | 1989 | 3 | |
| 13 | 2014 | 2 | |
| 14 | 1984 | 2 | |
| 15 | 2011 | 1 | |
| 16 | 2022 | 1 |
About Daniel Wagner
Daniel Wagner is a scholar working on Pharmacology, Pharmaceutical Science, Analytical Chemistry, Pharmacology and Pediatrics, Perinatology and Child Health, having authored 16 papers that have together received 392 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (2 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Drug Solubulity and Delivery Systems (2 papers), Cardiac Imaging and Diagnostics (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Urinary Tract Infections Management (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Statistical Methods in Clinical Trials (1 paper). The work is most often cited by research in Pharmaceutical Science (101 citations), Pharmacology (56 citations), Oncology (96 citations), Anesthesiology and Pain Medicine (19 citations) and Cardiology and Cardiovascular Medicine (62 citations). Daniel Wagner has collaborated with scholars based in United States, Germany and Luxembourg. Frequent co-authors include Peter Langguth, Hilde Spahn-Langguth, W.P. Jones, E. H. Flewellen, Abeer Hanafy, JOHN D. CONKLIN, Michael B. Bolger, Wolfgang Tremel, R. Wanitschke and Hildegard Spahn‐Langguth. Their work appears in journals such as British Journal of Pharmacology, International Journal of Pharmaceutics, Journal of Pharmaceutical Sciences, Strahlentherapie und Onkologie and Advanced Drug Delivery Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.